Speeding up time-to-market
White Paper Jan 24, 2012
University Hospital of Mannheim
In the hyper-competitive pharmaceuticals and biotechnology markets, companies face a litany of challenges, from stricter regulatory guidelines and rising development costs to the pressures of globalization. To succeed under these conditions, pharmaceuticals and biotech firms are finding it critical to reduce their time-tomarket, thus creating competitive advantage and maximizing near-term sales.
Unfortunately, the actual time required to develop a new product is not easy to shorten. Sometimes, however, firms can streamline the product transfer phase of development, speeding the time to commercial production. Both experience and expertise are critical in developing the correct methodology, which allows for significant reduction of development time while maintaining product quality.
Related White Papers
A Buyer's Guide to Protein Stability Measurement PlatformsWhite Paper
Malvern Instruments Limited
This buyer's guide discusses the available instrumentation for protein stability characterization, and what to consider when choosing stability assays.READ MORE